Assessment of diagnostic capacity and decision-making based on the 2015 American Thyroid Association ultrasound classification system
Open Access
- 20 May 2022
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Methodology
- Vol. 12 (3) , 148-163
Abstract
This study evaluates the American Thyroid Association (ATA) ultrasound (US) classification system for the initial assessment of thyroid nodules to determine if it indeed facilitates clinical decision-making. To perform a systematic review and meta-analysis of the diagnostic value of the ATA US classification system for the initial assessment of thyroid nodules. In accordance with the PRISMA statement for diagnostic test accuracy, we selected articles that evaluated the 2015 ATA US pattern guidelines using a diagnostic gold standard. We analyzed these cases using traditional diagnostic parameters, as well as the threshold approach to clinical decision-making and decision curve analysis. We reviewed 13 articles with 8445 thyroid nodules, which were classified according to 2015 ATA patterns. Of these, 46.62% were malignant. No cancer was found in any of the ATA benign pattern nodules. The Bayesian analysis post-test probability for cancer in each classification was: (1) Very-low suspicion, 0.85%; (2) Low, 2.6%; (3) Intermediate, 6.7%; and (4) High, 40.9%. The net benefit (NB), expressed as avoided interventions, indicated that the highest capacity to avoid unnecessary fine needle aspiration biopsy (FNAB) in the patterns that we studied was 42, 31, 35, and 43 of every 100 FNABs. The NB calculation for a probability threshold of 11% for each of the ATA suspicion patterns studied is less than that of performing FNAB on all nodules. These three types of analysis have shown that only the ATA high-suspicion diagnostic pattern is clinically useful, in which case, FNAB should be performed. However, the curve decision analysis has demonstrated that using the ATA US risk patterns to decide which patients need FNAB does not provide a greater benefit than performing FNAB on all thyroid nodules. Therefore, it is likely that a better way to approach the assessment of thyroid nodules would be to perform FNAB on all non-cystic nodules, as the present analysis has shown the ATA risk patterns do not provide an adequate clinical decision-making framework.Keywords
This publication has 62 references indexed in Scilit:
- Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3Orphanet Journal of Rare Diseases, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Pearls and Pitfalls of Thyroid Nodule Sonography and Fine-Needle AspirationUltrasound Quarterly, 2010
- Systematic Reviews of Diagnostic Test AccuracyAnnals of Internal Medicine, 2008
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006
- Importance of the Intraoperative Identification of the External Branch of the Superior Laryngeal Nerve During Thyroidectomy: Electromyographic EvaluationThyroid®, 2005
- Complications of Thyroid Surgery: Analysis of a Multicentric Study on 14,934 Patients Operated on in Italy over 5 YearsWorld Journal of Surgery, 2004
- Threshold Analysis via the Bayes' NomogramMedical Decision Making, 1991
- Threshold Analysis of Decision TablesMedical Decision Making, 1986
- The Threshold Approach to Clinical Decision MakingNew England Journal of Medicine, 1980